Salmon rickettsial syndrome: what is it, causes, symptoms, prevention

In the relentless pursuit of sustainable aquaculture, insidious threats often emerge from the microscopic world, capable of undermining entire industries. Among these, Piscirickettsia salmonis stands as a particularly formidable adversary. This globally distributed intracellular bacterium is the causative agent of piscirickettsiosis, a devastating disease primarily affecting salmonid species and responsible for substantial economic losses in farmed fish populations worldwide.

The pervasive reach of an intracellular foe

Piscirickettsia salmonis has been identified in numerous salmonid species, including Atlantic salmon (Salmo salar), coho salmon (Oncorhynchus kisutch), and rainbow trout (Oncorhynchus mykiss), which are critical to global aquaculture production. While originally identified in Chile in 1989, where it continues to cause significant annual losses, its presence has since been confirmed in other major salmon-producing regions, including Norway, Canada, Ireland, Scotland, and even Tasmania. This widespread distribution underscores the pathogen’s adaptability and the pervasive challenge it poses to the industry.

The bacterium primarily infects and replicates within the cytoplasmic vacuoles of phagocytic cells, such as macrophages and monocytes, effectively evading the host’s immune response. The disease progression in infected fish can be subtle initially, but often escalates to high mortality rates, sometimes reaching up to 90% in highly susceptible species like coho salmon. Infected farms typically experience mortality rates of 30-35% in their stock, highlighting the severe impact on production.

Clinical manifestations and pathological landscape

The clinical signs of piscirickettsiosis can be varied, making early detection a considerable challenge. Farmers might observe increased mortality, loss of appetite, emaciation, and lethargic swimming patterns. Fish may swim near the surface or along the sides of pens, and some may exhibit circling behavior.

Internally, the pathological changes are often more pronounced and widespread, reflecting the systemic nature of the infection. Gross pathological signs include:

• Skin lesions: ranging from raised scales and white plaques to shallow ulcers on the flanks and head.
• Generalized signs: darkening of the skin, pale gills, and a swollen abdomen (ascites).
• Organ damage: enlarged, grey, and mottled spleen and kidneys due to diffuse hemorrhages or necrotic lesions. The liver can also show similar mottling or ring-shaped white to pale-yellow lesions.
• Internal hemorrhages: petechial hemorrhages (pinpoint spots) in the gastrointestinal tract, swim bladder, and visceral fat. Signs of peritonitis, including generalized diffuse inflammation of abdominal organs and adhesions, are also common.

At a microscopic level, vasculitis and necrosis in the liver and kidney, along with inflammatory macrophage infiltration containing rickettsia-like organisms, are characteristic.

See all feed additives for fish

The economic burden and the antimicrobial dilemma

The economic repercussions of Piscirickettsia salmonis are staggering. In Chile, where the disease is endemic and highly prevalent, annual losses to the aquaculture industry have been estimated at hundreds of millions of USD, reaching as high as $700 million. This immense financial impact stems from direct fish mortalities, reduced growth rates, increased production costs due to treatments, and potential trade restrictions.

Historically, and still predominantly, antibiotics have been the primary line of defense against piscirickettsiosis. Florfenicol and oxytetracycline are frequently employed, particularly in the Chilean salmon farming industry, which has one of the highest rates of antibiotic consumption per ton of harvested fish globally. However, this reliance on antimicrobials presents significant challenges:

• Antimicrobial resistance: the extensive and often prolonged use of antibiotics fosters the development of antimicrobial resistance in P. salmonis, diminishing the efficacy of these crucial treatments over time.
• Environmental impact: incomplete metabolization of antibiotics by fish leads to their accumulation in marine sediments, raising concerns about environmental pollution and potential disruption of aquatic ecosystems.
• Market acceptability: traces of antibiotics in harvested fish can negatively impact market perceptions and lead to trade barriers, making products less attractive internationally.

The frequent failure of antibiotic treatments to completely control outbreaks, coupled with concerns about resistance and environmental impact, underscores the urgent need for alternative and more sustainable management strategies.

Towards sustainable control: vaccines and nutritional interventions

The challenges posed by P. salmonis have spurred significant research and development into more sustainable control measures. Vaccination remains a cornerstone of preventative immunological strategies. While various commercial vaccines have been developed and utilized for over three decades, their efficacy in real-world aquaculture settings has been variable. Factors such as water temperature during immunization can significantly impact vaccine protection, especially for live attenuated vaccines. For example, some vaccines show reduced efficacy at lower temperatures, emphasizing the need for meticulous management of environmental conditions during vaccination protocols. Oral immunizations have also been explored as a less stressful alternative, capable of maintaining long-term antibody levels.

Beyond vaccination, a holistic approach to fish health management is gaining traction, focusing on strengthening the fish’s natural defenses and resilience. This includes:

• Optimized farm management: reducing stress factors such as high stocking densities and abrupt transitions from freshwater to seawater, which can immunosuppress fish and make them more susceptible to infection.
• Environmental monitoring: understanding and managing environmental factors like water temperature, which plays a critical role in facilitating P. salmonis infection and triggering outbreaks.
• Nutritional support: the role of nutrition in modulating fish immunity and resistance to diseases like piscirickettsiosis is increasingly recognized. Research is exploring how specific dietary components can enhance fish health, improve gut integrity, and provide antimicrobial support.

Vetagro, for instance, offers advanced nutritional solutions for these issues with a unique blend of botanicals and organic acids with high antimicrobial and immune boosting properties, validated in salmon after years of collaboration with universities in Chile. This innovative product is designed to optimize immune response and directly target Piscirickettsia salmonis and modulate infection in salmon. Utilizing patented microencapsulation technology, results ensure that active ingredients are protected from leaching in water and thermal stress during feed manufacturing, allowing them to reach the orofecal route where they can exert their beneficial effects. This targeted delivery maximizes effect at lower inclusion rates, offering a crucial component in supporting fish health and resilience against pathogens.

The ongoing diversification and evolution of P. salmonis through genetic isolation and transposition bursts present continuous challenges, necessitating dynamic approaches to disease management. By combining improved diagnostic tools, advanced vaccine development, and sophisticated nutritional strategies, the aquaculture industry can move towards a more resilient and sustainable future.